New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 20, 2013
09:08 EDTSTEMStemCells expands patent portfolio
StemCells announced that it has acquired from NsGene A/S, a privately held Danish biotechnology company, a patent family claiming GFAP+ Nestin+ cells, including U.S. Patent Nos. 6,878,543 and 7,303,912 and European patent application 00973148. GFAP and Nestin are proteins that are co-expressed by certain key cells found in the human central nervous system. Each patent claims a cell culture of undifferentiated GFAP+ Nestin+ cells wherein one or more cells have the capacity to differentiate into neurons and glia as do many neural stem and progenitor cells described by researchers. The invention claimed by the patents resulted from research conducted at NsGene while in pursuit of cell-based treatments for Parkinson's disease. The terms of the patents extend into 2020 and 2021.
News For STEM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 26, 2015
10:04 EDTSTEMStemCells reports top line results for Phase I/II study in dry AMD
Subscribe for More Information
June 22, 2015
07:05 EDTSTEMStemCells data likely to be positive, says Cantor
Subscribe for More Information
June 18, 2015
09:04 EDTSTEMOn The Fly: Pre-market Movers
Subscribe for More Information
08:07 EDTSTEMStemCells Phase II Pathway Study approved by Health Canada
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use